CTCL
10 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL (NCT03240211) | University of Virginia | 2022-02-02 |
| StrataCTX® as a Steroid Sparing Device (NCT04087629) | Columbia University | 2021-07-07 |
| A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL) (NCT04171791) | Yale University | 2020-01-15 |
| A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL (NCT03239392) | Bioniz Therapeutics | 2018-04-01 |
| Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL (NCT02757248) | Anne Beaven, MD | 2016-11-01 |
| A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors (NCT02556463) | MedImmune LLC | 2015-11-04 |
Track CTCL automatically
Every clearance here is in the API, with alerts when new ones post.